Canaan on Twitter
Canaan on LinkedIn
© Copyright 2019 Canaan |
Latest for Nocion
Julie Grant: Announcing Nocion Therapeutics, a novel approach to neurogenic inflammation
Today, Canaan proudly introduces Nocion Therapeutics, a Series A neurogenic inflammation and analgesic company discovering and developing novel pharmaceutical treatments for various indications including pain, cough and itch.
FierceBiotech: Nocion Therapeutics named to Fierce 15
While whole shoals of biotechs are clustered around single cancer targets, Nocion is away from the pack working on better ways to treat conditions...
Business Insider: Nocion raises $27M to make a new kind of painkiller as the race to replace opioids heats up
As America grapples with a deadly opioid epidemic, there's a desperate need for better, non-addictive painkillers. Using science out of Harvard and...
FierceBiotech: Nocion launches with $27M and 'charged drugs' to selectively target pain
STAT News: How one company, Nocion, thinks unraveling cough can provide a new way to treat pain